Development of an integrated continue cgmp facility for mrna manufacturing - BAA-pmqwp#364
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40122C00200
- Awardee
-
Massachusetts Institute Of Technology UEI E2NYLCDML6V1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $82,182,000
Award facts
- Opportunity
-
- FY22 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Solicitation · FDABAA2200123 · Posted Nov 10, 2021
- Contract value 100% obligated
- $82,182,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541720 Research and Development in the Social Sciences and Humanities
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $82,182,000 |
About this award
This is a Definitive Contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) for the development of an integrated cGMP facility for mRNA manufacturing. The contract is valued at $82,182,000.00 and has a completion date of September 28, 2026. It is a Firm Fixed Price contract with no set-aside designation.
MIT has subcontracted with The Pennsylvania State University and Rensselaer Polytechnic Institute to perform research related to mRNA manufacturing processes and rapid mRNA vaccine production methods. The contract was awarded under a Broad Agency Announcement (BAA) solicitation from the FDA seeking proposals to advance regulatory science and support the development of new tools, standards, and approaches for evaluating FDA-regulated products. The BAA remains open for consideration in future fiscal years.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| The Pennsylvania State University | $250,395 | |
| Rensselaer Polytechnic Institute | $490,907 | |
| Arranta Bio Ma LLC | $62,024,000 |
Quick answers
Who was awarded contract 75F40122C00200?
75F40122C00200 was awarded to Massachusetts Institute Of Technology by Food and Drug Administration (Department of Health and Human Services) on September 28, 2022.
How much is contract 75F40122C00200 worth?
The government has obligated $82,182,000 on 75F40122C00200.
Was contract 75F40122C00200 competed?
The extent of competition for 75F40122C00200 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award